Real world challenges and disparities in the systemic treatment of ovarian cancer

被引：3

作者：

Nogueira-Rodrigues, Angelica ^{[1
,4
]}

Giannecchini, Giovanna Vieira ^{[2
]}

Secord, Angeles Alvarez ^{[3
]}

机构：

[1] Fed Univ MG, Brazilian Grp Gynecol Oncol EVA, Latin Amer Cooperat Oncol Grp LACOG, Oncoclin,DOM Oncol, Pampulha, Brazil

[2] Oncoclinicas, Brasilia, Brazil

[3] Duke Univ Hlth Syst, Duke Canc Inst, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC USA

[4] Ave Prof Alfredo Balena 110,110 St Efigenia, BR-30130100 Belo Horizonte, MG, Brazil

来源：

GYNECOLOGIC ONCOLOGY | 2024年 / 185卷

关键词：

Ovarian cancer care; Real world challenges; Disparities in access to treatment; GYNECOLOGIC CANCER; COUNTRIES;

D O I：

10.1016/j.ygyno.2024.02.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian cancer (OC) is a global health problem, and the mortality -to -incidence ratio is expected to increase, especially in low- and middle -income countries. These regions face disparities in access to OC care, including lack of awareness, limited access to genetic and tumor testing, paucity of surgical expertise, time to approval of novel therapeutics, and treatment costs. By addressing these inequities, the core aim of this paper is to promote action through collaboration in order to overcome these barriers and promote health equity in OC management and treatment. (c) 2024 Published by Elsevier Inc.

引用

页码：180 / 185

页数：6

共 50 条

[1] Disparities in biomarker testing in ovarian cancer: a real-world analysis
Smith, Anna Jo Bodurtha
Alvarez, Rafael
Heintz, Jonathan
Haggerty, Ashley
Ko, Emily M.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : 98 - 100
[2] Real-world evidence in the treatment of ovarian cancer
Eisenhauer, E. A.
ANNALS OF ONCOLOGY, 2017, 28 : 61 - 65
[3] Disparities in clinical trial participation in ovarian cancer: A real-world analysis
Smith, Anna Jo Bodurtha
Alvarez, Rafael
Heintz, Jonathan
Simpkins, Fiona
Ko, Emily M.
GYNECOLOGIC ONCOLOGY, 2023, 175 : 25 - 31
[4] REAL-WORLD EVALUATION OF HEALTH DISPARITIES IN TREATMENT PATTERNS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
Nayak, P.
Cyhaniuk, A.
Prasad, S.
Pfeffer, D.
Shokoohi, M.
Kish, J.
VALUE IN HEALTH, 2023, 26 (06) : S207 - S207
[5] Real-world experience with trabectedin for the treatment of recurrent ovarian cancer
Romero, Ignacio
Lopez-Guerrero, Jose Antonio
Pignata, Sandro
EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (10) : 1089 - 1095
[6] REAL-WORLD OF OVARIAN CANCER TREATMENT OUTCOMES IN NORTHERN PORTUGAL
Savva-Bordalo, J.
Magalhaes, M.
Calisto, R.
Redondo, P.
Borges, M.
Petiz, A.
Bento, M. J.
Pereira, D.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A274 - A275
[7] A real-world analysis of the treatment of advanced ovarian cancer with PARPIs
de Pinillos, A. Martinez
Anger, C.
Mendoza, L.
ANNALS OF ONCOLOGY, 2019, 30
[8] Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
Cheeseman, Sue
Levick, Bethany
Sopwith, Will
Fenton, Hayley
Nam, Eun Ji
Kim, DongKyu
Lim, Subin
Martin, Elodie
Frenel, Jean-Sebastien
Bocquet, Francois
Kubelac, Paul
Achimas-Cadariu, Patriciu
Vlad, Catalin
Chevrier, Marion
Rouzier, Roman
Carton, Matthieu
Savva-Bordalo, Joana
Magalhaes, Marta
Borges, Marina
Wolf, Andrea
Becker, Sven
Niklas, Nicolas
Guergova-Kuras, Mariana
Hall, Geoff
FRONTIERS IN ONCOLOGY, 2023, 13
[9] The Challenges of Managing Ovarian Cancer in the Developing World
Mulisya, Olivier
Sikakulya, Franck K.
Mastaki, Mbusa
Gertrude, Tambavira
Jeff, Mathe
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
[10] Systemic treatment of primary ovarian cancer
Selcuk, Ilker
Yaznil, Muhammad Rizki
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : 5 - 6

← 1 2 3 4 5 →